COMMUNIQUÉS West-GlobeNewswire

-
Women, Men Say More Solutions Needed In The Workplace In Light Of #MeToo, Survey Reveals
02/05/2018 -
TOMI™ Environmental Solutions, Inc. Announces New Sales Leadership
02/05/2018 -
Yield Endurance Strategic Partner Closes on Initial Loan of 110 Bitcoins
02/05/2018 -
SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement
02/05/2018 -
Asterias Biotherapeutics to Present Safety and Efficacy Data from AST-OPC1 SCiStar Study at the American Spinal Injury Association (ASIA) 2018 Annual Meeting
02/05/2018 -
ChemoCentryx to Hold First Quarter 2018 Financial Results Conference Call on Wednesday, May 9, 2018
02/05/2018 -
Rockwell Medical Announces Triferic® Presentations at the 2018 International Congress on Peritoneal Dialysis
02/05/2018 -
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent regarding Methods of Production for AV-101
02/05/2018 -
Hemispherx Provides an Update to Stockholders Highlighting Cancer Focus and $10 Million Booked Since Start of Year Will Support Increased Production of Ampligen for Immuno-Oncology Clinical Trials
02/05/2018 -
Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018
02/05/2018 -
Trading by management and close relations of management
02/05/2018 -
Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018
02/05/2018 -
Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May
02/05/2018 -
Endocyte Announces First Quarter 2018 Earnings Call
02/05/2018 -
Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference
02/05/2018 -
Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call
02/05/2018 -
AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer
02/05/2018 -
Jounce Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
02/05/2018 -
Cellectar Receives Rare Pediatric Disease Designation for CLR 131 to Treat Neuroblastoma
02/05/2018
Pages